HC Deb 18 April 2002 vol 383 c1175W
Mr. Hancock

To ask the Secretary of State for Health what the cost is of the assessment of the drug Glivec for chronic myeloid leukaemia; and if he will make a statement. [41598]

Yvette Cooper

The National Institute for Clinical Excellence (NICE) is currently appraising Glivec for the treatment of chronic myeloid leukaemia. As this appraisal is ongoing it is not possible at this time to give a cost of the assessment of Glivec.